Medical College of Wisconsin

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Medical College of Wisconsin sits in the top decile of US sponsors by registered trial count (#79 of 15,742 sponsors by registered trial count).

447 total trials 95 currently recruiting 236 completed early-phase tilt top decile by trial count

Medical College of Wisconsin: 447 sponsored US clinical trials, 95 recruiting.

Medical College of Wisconsin sponsors 447 registered US clinical trials on ClinicalTrials.gov, 95 of them currently recruiting, and 236 completed. 28 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 10 trials.

Top-decile sponsor footprint

Medical College of Wisconsin ranks in the top decile of sponsors by registered trial count (#79 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 46/100

236 of 286 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

447 total, page 8 of 9

COMPLETED NA

Validation Durability Adenosine Effect in Verification Pulmonary Vein Isolation

NCT01590875

COMPLETED

Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation

NCT02348684

COMPLETED

Plastic Bronchitis and Protein Losing Enteropathy in Children With Single Ventricle Physiology

NCT01563757

COMPLETED Phase 1

Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV

NCT01535885

COMPLETED NA

Evaluating a New Way to Prepare Parents of Hospitalized Children for Discharge and Management of Child at Home

NCT01565785

COMPLETED NA

Improving Hypertension Control

NCT01910857

COMPLETED

Improving Nutrient Intake and Growth in Children With Multiple Food Allergies

NCT01571830

COMPLETED Phase 2

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

NCT01726582

COMPLETED NA

Effect of a Social Script iPAD Application for Children With Autism Spectrum Disorder

NCT01655485

COMPLETED Phase 2

Allogeneic Transplant in HIV Patients (BMT CTN 0903)

NCT01410344

TERMINATED NA

Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression

NCT01412918

TERMINATED Phase 1

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

NCT01475162

COMPLETED NA

Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM)

NCT01825252

COMPLETED Early Phase 1

Mechanisms of Neuromuscular Fatigue Post Stroke

NCT01688570

TERMINATED Phase 1

Antithrombin III Supplementation for Cardiopulmonary Bypass in Neonates

NCT01158729

TERMINATED Phase 1

Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)

NCT01389817

COMPLETED NA

Video Education Intervention in the Emergency Department

NCT01471769

TERMINATED Phase 3

Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

NCT01339910

COMPLETED NA

Exercise and Stress Management Post Autologous and Allogeneic Transplant (BMT CTN 0902)

NCT01278927

COMPLETED Phase 2

Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis

NCT01197417

COMPLETED

Radiation Biodosimetry in Children Undergoing Total Body Irradiation

NCT01337648

TERMINATED NA

Vitamin D Deficiency and Atopic Dermatitis

NCT01337635

TERMINATED

Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis

NCT01234909

COMPLETED NA

Overcoming Inactivity in Older Adults: Impact on Vascular Homeostasis

NCT01212978

TERMINATED Phase 1

Selenium in the Treatment of Complicated Lymphatic Malformations

NCT01212965

COMPLETED

Parents of Pediatric Solid Organ Transplant Recipients: Transition to Home and Chronic Illness Care

NCT01389804

COMPLETED

Atrioventricular Valve Regurgitation Vena Contracta; Echo Versus MRI

NCT01504880

COMPLETED Phase 2

Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)

NCT01106833

COMPLETED Phase 2

Autologous Transplant in HIV Patients (BMT CTN 0803)

NCT01141712

COMPLETED NA

Effect of Early Rest on Recovery From Pediatric Concussion

NCT01101724

COMPLETED NA

Simple Technique to Improve Diagnostic Yield in EUS-FNA

NCT01995474

COMPLETED Phase 3

Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)

NCT01002742

COMPLETED

Longitudinal Study of Neurologic, Cognitive, and Radiologic Outcomes of PHACE Syndrome

NCT01018082

COMPLETED

An Evaluation of Routine Developmental Follow-Up in Infants and Children With Congenital Heart Disease

NCT01567579

COMPLETED

Placental and Cord Blood Markers Associated With Premature Birth and Disorders of Premature Birth in Newborn Infants

NCT01439048

COMPLETED Phase 2

Hematopoietic Stem Cell Transplant for Fanconi Anemia

NCT01071239

COMPLETED NA

Improving Parental Knowledge: Supplementation of Prematurity Counseling With Written Information

NCT01418950

COMPLETED Phase 2

Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)

NCT00912223

COMPLETED

Advanced MRI Sequences for Radiation Therapy Treatment Planning

NCT02340715

COMPLETED

Fecal Calprotectin in Cystic Fibrosis

NCT00863694

TERMINATED NA

Reducing Barriers to Behavior Change Among Youth With Pediatric Overweight and Obesity

NCT00863083

COMPLETED

Pre-arrival Instructions Effect on Bystander Cardiopulmonary Resuscitation (CPR).

NCT02007499

COMPLETED

Transition From Hospital to Home in Solid Organ Transplant (SOT)

NCT00907023

COMPLETED

Parenting After Infant Congenital Heart Defect Diagnosis

NCT01503307

COMPLETED Phase 2

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

NCT00864227

COMPLETED NA

Trial of Montelukast for Treatment of Acute Bronchiolitis

NCT00863317

COMPLETED Phase 1

Functional Magnetic Resonance Imaging (fMRI) and Robot-Assisted Practice of Activities of Daily Living

NCT00878085

COMPLETED NA

Caring for Those Who Share: Improving the Health of Wisconsin Blood Donors

NCT00772083

COMPLETED NA

Vascular Malformations and Abnormalities of Growth

NCT01105676

COMPLETED Phase 2

Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations

NCT00698529

← Previous Page 8 of 9 Next →

Phase Distribution

PhaseTrial count
Phase 1 49
Phase 2 80
Phase 3 13
Phase 4 15

What is open in the Medical College of Wisconsin pipeline

95 recruiting of 447 indexed (21% open); 236 completed (53%).

Phase mix: 28 late (III/IV) vs 129 early (I/II) (early-phase heavy).

Top condition: Stroke (10 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Medical College of Wisconsin: open-pipeline peers nationwide

Peers matched on 447 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

Medical College of Wisconsin sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600 5%10%15%20%25% Total trials Recruiting share Medical College of WisconsinAlliance for Clinical Trials in OncologyUniversity of VirginiaBoston Children's HospitalChildren's Hospital of PhiladelphiaColorado State UniversityUniversity of LouisvilleOhio State UniversityNova Southeastern University
Medical College of Wisconsin sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Medical College of Wisconsin sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 447 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this Medical College of Wisconsin page

447 registered trials is a research-attention snapshot, not an endorsement of Medical College of Wisconsin or any single study.

  • 95 of Medical College of Wisconsin's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition Medical College of Wisconsin studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical College of Wisconsin pipeline card: 447 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.